20 Minutes With: Preslav Raykov, Eleen Marine

In:

Metals and Mining, Oil & gas

Ralph Ivey

Commodities Editor

TXF spoke with Preslav Raykov, global head of trading at Eleen Marine about the importance of risk controls in the present geopolitical environment as well as strategies for aligning stakeholders across commodity supply chains.

Exclusive subscriber content…

If you are a TXF subscriber, please login to continue reading

Not yet a subscriber? Join us today to continue accessing content without any restrictions

View our subscription options

Or to request access to TXF Intelligence contact us

Request Access

Dangote scales up amid energy market turmoil

Perspective

20 April 2026

Dangote scales up amid energy market turmoil

Afreximbank has signed on fresh financing for Nigeria’s oil & gas industry at a moment of crisis for the global energy business. The conflict in the Gulf has further...

Perspective

24 April 2026

Jabiru-1: Who’s out of orbit?

The financial fallout from NewSat's failed Jabiru-1 satellite project financing could be stratospheric. Investors are claiming $1 billion or more in damages from banks as part...

Must See

Video

07 April 2026

Crisis in the Gulf: Sullivan & Worcester on trade under pressure

TXF speaks to Sullivan & Worcester partner Robert Parson about trade disputes, credit escalation and the flight to size as the crisis in the Gulf continues.

Perspective

20 April 2026

Dangote scales up amid energy market turmoil

Afreximbank has signed on fresh financing for Nigeria’s oil & gas industry at a moment of crisis for the global energy business. The conflict in the Gulf has further underlined the fragility of international supply chains, but are West African producers set to take advantage?

Perspective

24 April 2026

Jabiru-1: Who’s out of orbit?

The financial fallout from NewSat's failed Jabiru-1 satellite project financing could be stratospheric. Investors are claiming $1 billion or more in damages from banks as part of an ongoing lawsuit – but why did lenders and ECAs struggle to find a default cure?